Home → Best Practices

Best Practices
Ohio health system says it cut opioid prescriptions for acute pain by 62% Print E-mail
Written by Tina Reed | Fierce Healthcare   
Friday, 06 July 2018 16:23
An electronic medical record system is being credited with helping a public health system in Ohio reduce its opioid prescriptions for acute pain by more than 60% in the last 18 months. Officials from Cleveland-based MetroHealth System said they also cut opioid prescriptions by 25% for chronic pain. In all, they estimate they cut opioid prescriptions by 3 million pills. How'd they do it? Officials pointed to the alerts they set up in the EMR system. In particular, those alerts for prescribers were set up to flag patients who may be at risk for addiction to guide them toward alternative drugs and lower doses.
Read More

Last Updated on Friday, 06 July 2018 16:24
Cost Issues Prevent a Quarter of Patients From Taking Insulin Print E-mail
Written by Becky McCall | Medscape   
Tuesday, 26 June 2018 17:08
6.23.18 - Orlando - Cost issues related to insulin use prevent a full quarter of patients with diabetes taking insulin as prescribed, and this is associated with poorer glycemic control, shows a new study. Low to middle income patients were worse off, the data indicate. Patients in the $25,000 to $99,000 income bracket were significantly more likely to underuse insulin because of cost barriers, Darby Herkert, BS, from Yale University, New Haven, Connecticut, reported here today at the American Diabetes Association (ADA) 2018 Scientific Sessions.  
Read More (Log in/complimentary subscription required.)

Last Updated on Tuesday, 26 June 2018 17:11
The Women's Libido Pill Is Back, and So Is the Controversy Print E-mail
Written by Cynthia Koons | Bloomberg via Yahoo! Finance   
Tuesday, 19 June 2018 17:09
This past January, when Cindy Eckert got back the keys to her old office in Raleigh, N.C., she walked into a time capsule. An empty water glass still sat on the receptionist's desk. Piles of marketing materials were gathering dust. Boxes with three-year-old FedEx labels had never been shipped. It was the first time Eckert had entered the office since she sold-and was then pushed out of-her company, Sprout Pharmaceuticals Inc. She and her then-husband started the company to bring to market the first drug to enhance female sexual desire. Since that moment, the story of Addyi, the pink pill, has been frozen in time.
Read More

Last Updated on Monday, 23 July 2018 13:49
WHO releases new International Classification of Diseases Print E-mail
Written by FHI's Week in Review   
Monday, 18 June 2018 16:54
The World Health Organization (WHO) has just released its new International Classification of Diseases (ICD-11).
Read more in the current issue of Week in Review>>
Last Updated on Monday, 18 June 2018 16:57
'End of an Era' for Chemo in Non-Small Cell Lung Cancer Print E-mail
Written by FHI's Week in Review   
Monday, 04 June 2018 16:48
Liam Davenport reports for Medscape on June 03, 2018 that most patients with advanced non-small cell lung cancer (NSCLC) can now avoid having chemotherapy as a first-line treatment, after a large, randomized trial showed that immunotherapy with the programmed cell death ligand 1 (PD-L1) blocker pembrolizumab (Keytruda, Merck) is effective even in patients with minimal PD-L1 expression.
Read more in the current issue of Week in Review>>
Last Updated on Monday, 02 July 2018 16:31
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Page 6 of 70

Website design, development, and hosting provided by